FDA Clearance Tracker · P030006-S028
Prolieve Thermodilation System
Last checked: Nov 20, 2026Latest source record: Nov 21, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Nov 21, 2018
Approved
Time to decision
236 days
Received Mar 30, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P030006-S028
- Device name
- Prolieve Thermodilation System
- Applicant
- Medifocus, Inc.
- Applicant location
- Columbia, MD
- Received
- Mar 30, 2018
- Decided
- Nov 21, 2018
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P030006
Device type
- Device class
- Class III
- Specialty
- GI, Urology & NephrologyUrology
FDA's approval statement
As written in FDA's record.
Approval for a labeling update with the results of the Post Approval Study (PAS)
Source documents
Other decisions for Medifocus, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.